Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: Evidence that serum PSA is a marker of androgen action in women

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 81-84

  Negri, Carlo ^a   Tosi, Flavia ^a   Dorizzi, Romolo ^b   Fortunato, Antonio ^c   Spiazzi, Giovanna Gloria ^a   Muggeo, Michele ^a   Castello, Roberto ^a   Moghetti, Paolo ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANEDIOL; ANTIANDROGEN; BIOLOGICAL MARKER; FINASTERIDE; FLUTAMIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SPIRONOLACTONE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; FEMALE; HIRSUTISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; MEASUREMENT; PRIORITY JOURNAL;

ADULT; ANDROGEN ANTAGONISTS; ANDROGENS; ANDROSTANE-3,17-DIOL; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; FINASTERIDE; FLUTAMIDE; HIRSUTISM; HUMANS; PROSTATE-SPECIFIC ANTIGEN; SPIRONOLACTONE; TESTOSTERONE;

EID: 0034457729     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.81     Document Type: Article

References (16)

1. Structure, function, and regulation of the enzyme activity of prostate-specific antigen
2. Measurement of prostate specific antigen in serum as a screening test for prostate cancer
3. Ultrasensitive prostate specific antigen assays and their clinical application
4. Nonprostatic sources of prostate-specific antigen
5. Prostate-specific antigen in female serum, a potential new marker of androgen excess
6. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function
7. Established biochemical markers vs. serum prostate-specific antigen assay in the assessment of hyperandrogenism
8. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized double blind, placebo-controlled trial
9. Hirsutism: Implications, etiology, and management
10. Clinical and hormonal effects of the 5α-reductase inhibitor finasteride in idiopathic hirsutism
11. Hirsutism and the effectiveness of spironolactone in its management
12. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
13. Finasteride
14. The effect of finasteride on prostate specific antigen: Review of available data
15. Prostate specific antigen in black and white men after hormonal therapies for prostate cancer
16. Serum prostate specific antigen is significantly elevated after testosterone administration in female to male transsexuals